about
Metformin in polycystic ovary syndrome: systematic review and meta-analysisInsulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertilityLifestyle changes in women with polycystic ovary syndromeInsulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertilityInsulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertilityLeptin and leptin receptor expression in the rat ovaryClinical effectiveness of elective single versus double embryo transfer: meta-analysis of individual patient data from randomised trialsCriteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society GuidelinePolycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment.Obesity, polycystic ovary syndrome and anovulation--how are they interrelated?Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis.Adipokines: implications for female fertility and obesity.Polycystic ovary syndrome and implications for the menopause.Hyperandrogenaemia and the ovary.The role of lifestyle modification in polycystic ovary syndrome.Programming and reproductive functioning.The obese patient with infertility: a practical approach to diagnosis and treatment.What should we do with donated embryos that may be genetically affected?Macrophage contributions to ovarian function.Improving reproductive performance in overweight/obese women with effective weight management.Single or multiple embryo transfer following in vitro fertilisation for improved neonatal outcome: a systematic review of the literature.Acupuncture to improve live birth rates for women undergoing in vitro fertilization: a protocol for a randomized controlled trial.Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome.PPAR Gamma: Coordinating Metabolic and Immune Contributions to Female Fertility.Quality management systems in ART: are they really needed? An Australian clinic's experience.Lifestyle choices, diet, and insulin sensitizers in polycystic ovary syndrome.Dietary therapy in polycystic ovary syndrome.Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysis.Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries.Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.Measurement of human chorionic gonadotrophin (hCG): indications and techniques for the clinical laboratory.Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society.Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.Aromatase inhibitors for PCOS: a systematic review and meta-analysis.The treatment of infertility in polycystic ovary syndrome: a brief update.Expression of leptin and its receptor in the murine ovary: possible role in the regulation of oocyte maturation.Metabolic risk in PCOS: phenotype and adiposity impact.The majority of irregular menstrual cycles in adolescence are ovulatory: results of a prospective study.Metabolic syndrome, diet and exercise.
P50
Q22242098-0A14E017-7179-4867-9489-28F84E0EFD7CQ24197673-92E4A6BB-466E-43F7-A8EF-DE79027444FEQ24235398-11F74EBE-7585-461E-AF5C-A23B1EAEAE0FQ24240501-C1176A35-F917-494A-8ADA-BBD68C5F3731Q24240654-ADB558C4-1279-49D7-BC14-CA48BCD157C2Q28567503-EAC2C2C7-BF92-4807-8ACC-606E04AC7A80Q28744051-55187616-F63E-49EC-8B51-8929D079AA07Q29301826-716B5C68-3EE4-4349-A533-D779E7EE8146Q34103535-8083DBE3-A364-4DB9-97E3-CA9FC3E2AFAFQ34276481-B32C1612-B95F-4FD2-8D5E-AE1FE2522141Q34298086-75274D20-7629-4C9A-95E2-F1F29A2967DBQ34464605-9DA07C89-4071-4D69-996C-17C0A9193E3AQ34575203-5B8ACB24-CD68-4D99-A599-B373B4FF20C8Q34667065-F34AE46E-37B0-4BBA-B4E7-5739D8CE2BCBQ34750810-F5080186-62BE-43F4-8A64-1382FC5E2031Q34942748-31661133-CED5-4A02-97D9-2BCF5CC0FC37Q35056545-0DE81BF8-8E2B-41DD-9FEA-DD9A87EAA65FQ35740712-3398AADD-EF89-47F1-B374-E30D6E325F60Q35741644-1E7E5BE9-6F2F-4049-A810-B03AC4152082Q35772125-CBA7385C-0AC0-4D03-9C5C-D1035605D77FQ35849702-AA7B5E29-C99C-4C88-8FCB-6404E84D7E06Q36299399-66083D08-9277-4C5B-851B-6C94A4401BD1Q36360786-3E9614EE-9AE6-452F-B1ED-26F1553606EFQ36465006-2570E604-C275-43F4-BFF9-4138DC2F7B52Q36644972-108AEC51-4F6F-4DAB-B51A-8AB4847EA297Q36690971-8062B67B-6EF7-4C76-924F-479807953068Q37052801-00F1F8EE-2CCE-4B78-8B38-4E65F1F3DF0AQ37300762-3933A79E-BB79-45B1-BE5B-C20299C2C908Q37343173-E96E3BAB-15C5-44A4-9372-3672E04C4E1AQ37419236-F7B2165B-469B-4D96-B72B-7D46E03E27D4Q37726592-AD90CBF5-65A4-4553-9BDB-67FC1F39AE11Q37946362-DED63A50-82D6-4D72-892D-97D9C9EBAA98Q37953819-D58ED933-93F7-4D94-B655-2A86A4F684DDQ37966293-89FE531F-559B-47A1-B140-262E97B78CC3Q37995144-00D92392-D87A-48A7-9266-9428392B3D27Q38013766-AA3369D0-13E1-4F67-B506-4CFB3E2BE966Q38289979-8438FEC4-C87C-4DB3-ADB5-001D99107670Q38319666-BF9B4955-9CD9-4594-AED5-1001A6BD8588Q38631714-B9D02293-DF2C-4B6A-A486-14B48B0EBD99Q38772694-FB2229CB-7B81-4987-A205-F81B720C2BE7
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Robert J Norman
@ast
Robert J Norman
@en
Robert J Norman
@es
Robert J Norman
@nl
Robert J Norman
@sl
type
label
Robert J Norman
@ast
Robert J Norman
@en
Robert J Norman
@es
Robert J Norman
@nl
Robert J Norman
@sl
altLabel
Rob
@en
prefLabel
Robert J Norman
@ast
Robert J Norman
@en
Robert J Norman
@es
Robert J Norman
@nl
Robert J Norman
@sl
P214
P244
P1053
A-1155-2007
P106
P21
P213
0000 0000 3911 337X
P214
P244
nb2007003601
P31
P3829
P496
0000-0002-3118-3896
P734
P735
P7859
lccn-nb2007003601